The mobile ecg devices market has seen considerable growth due to a variety of factors.
•In the past few years, the market size for mobile ECG devices has seen robust growth. The market is expected to expand from $115.35 billion in 2024 to $122.18 billion in 2025, marking a compound annual growth rate (CAGR) of 5.9%.
The surge in growth during the historic period can be credited to the integration with smartphones, clinical verification and research, adoption of telemedicine, shrinkage of tech size, enhanced connectivity, and a heightened awareness of health.
The mobile ecg devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the mobile ECG devices market to experience significant growth in the coming years. By 2029, the market size is predicted to reach $166.82 billion, expanding at a compound annual growth rate (CAGR) of 8.1%.
The projected growth during this period is linked to several factors, including the growing prevalence of cardiovascular diseases, aging populations, expansion of telehealth services, greater public awareness of health, and advancements in digital health. Key trends observed for the future include the prominence of personalized healthcare solutions, progress in regulatory measures, market expansions in budding economies, emphasis on user-friendly gadget designs, and growth in home healthcare services.
The increase in heart-related disorders is anticipated to stimulate advancement in the mobile ECG devices market. These disorders consist of an array of maladies that affect the heart and circulatory system, such as coronary and congenital heart diseases. Mobile ECG devices are predominantly use to identify conditions like myocardial infarction and cardiac arrhythmias, providing more effective supervision of heart disorders and minimizing the volume of untreated and overlooked cases. As evidence, the US-based government agency, Centers for Disease Control and Prevention reported in May 2024 that heart disease was responsible for 702,880 deaths in 2022 in the United States, contributing to 1 in every 5 fatalities. Consequently, the increasing prevalence of heart-related conditions is fuelling the expansion of the mobile ECG devices market.
The mobile ECG devices market covered in this report is segmented –
1) By Type: Monitoring ECG Systems, Diagnostics ECG Systems
2) By Modality: Handheld, Pen, Band, Other Modalities
3) By End User: Personal Users, Hospitals, Clinics, Ambulatory Services
Subsegments:
1) By Monitoring ECG Systems: Wearable ECG Monitors, Handheld ECG Monitors, Patch-Based ECG Monitors
2) By Diagnostics ECG Systems: Portable ECG Devices, Smartphone-Based ECG Devices, Holter Monitors
The adoption of cutting-edge technologies is a rising trend in the mobile ECG devices arena. Major players in the field maintain their market standing by embracing novel technologies. An exemplar of such advancements is the rollout of the KardiaMobile Card by AliveCor Inc., a medical device firm based in the US with a focus on AI, in February 2022. This device is the first personal ECG that's slim enough to be placed in a wallet, delivering prompt reports concerning cardiac health. It communicates with a smartphone using Bluetooth-enabled technology to detect six common arrhythmias. Its users get monthly heart health reports, automatic ECG record sharing, and an ECG analysis from a cardiologist. AliveCor's KardiaMobile Card, driven by its AI-supported Kardia technology, boasts an algorithm validated through over 170 peer-reviewed studies. This card is notably portable and long-lasting, enabling clients to conduct ECG tests anytime, anywhere. It also withstands various environmental conditions, including water and regular use.
Major companies operating in the mobile ECG devices market include:
• Medtronic PLC
• Koninklijke Philips N.V.
• GE Healthcare
• Omron Corporation
• Mindray Medical International Limited
• ZOLL Medical Corporation
• Nihon Kohden Corporation
• Spacelabs Healthcare
• Biotronik SE & Co KG
• Fukuda Denshi Co. Ltd.
• Bittium Biosignals Ltd.
• Contec Medical Systems Co. Ltd.
• Schiller AG
• Preventice Solutions Inc.
• BPL Medical Technologies Pvt. Ltd.
• AliveCor Inc.
• EB Neuro S.p.A
• Mednet Healthcare Technologies Inc.
• GETEMED Medical and Information
• QT Medical Inc.
• Qardio Inc.
• Innomed Medical Inc.
• MD Biomedical Inc.
• CardioComm Solutions Inc.
• Hexoskin
• VectraCor Inc.
• Cardiocity Limited
North America was the largest region in the mobile ECG devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile ECG devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.